Thu, Mar 30|
The future of Parkinson care
"Healthcare is in urgent need of a radical transformation, and the field of Parkinson’s disease is no exception."
Time & Location
Mar 30, 2023, 1:30 PM – Mar 31, 2023, 2:30 PM
About the event
You are invited to attend a presentation by Prof. Bastiaan R. Bloem, MD, PhD, FRCPE, Director, Radboudumc Center of Expertise for Parkinson & Movement Disorders, titled “The future of Parkinson care”.
Professor Bas Bloem is a consultant neurologist at the Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands. He received his medical degree, with honours, at Leiden University Medical Centre in 1993 and obtained his PhD degree in 1994. In September 2008, he was appointed professor of neurology, with movement disorders as special area of interest.
With an extensive publication record and international reputation Professor Bloem is past president of the International Society for Gait and Postural Research. He is also a past-Officer (Secretary) for the International Parkinson and Movement Disorder Society. In 2002, Professor Bloem founded and became director of the Radboudumc Centre of Expertise for Parkinson & Movement Disorders, which was recognised from 2005 onwards as a centre of excellence for Parkinson’s disease.
Professor Bloem has two main research interests: cerebral compensatory mechanisms, especially in the field of gait and balance; and healthcare innovation, aiming to develop and scientifically evaluate patient-centred collaborative care. Professor Bloem is cofounder of ParkinsonNet, which has received multiple awards.
“Healthcare is in urgent need of a radical transformation, and the field of Parkinson’s disease is no exception. In my presentation, I will discuss our experience in building integrated, multidisciplinary networks consisting of both specifically trained professionals and engaged, informed patients and caregivers. I will also discuss how technology can support such integrated care networks. Finally, I will address how the focus should shift from the current reactive approach to a more proactive approach, with a dedicated focus on several common, disabling and costly complications of Parkinson’s disease.”